Titlebook: Oral Complications of Cancer Chemotherapy; Douglas E. Peterson,Stephen T. Sonis Book 1983 Martinus Nijhoff Publishers, The Hague 1983 canc

Racket

書目名稱Oral Complications of Cancer Chemotherapy影響因子(影響力)




書目名稱Oral Complications of Cancer Chemotherapy影響因子(影響力)學科排名




書目名稱Oral Complications of Cancer Chemotherapy網(wǎng)絡公開度




書目名稱Oral Complications of Cancer Chemotherapy網(wǎng)絡公開度學科排名




書目名稱Oral Complications of Cancer Chemotherapy被引頻次




書目名稱Oral Complications of Cancer Chemotherapy被引頻次學科排名




書目名稱Oral Complications of Cancer Chemotherapy年度引用




書目名稱Oral Complications of Cancer Chemotherapy年度引用學科排名




書目名稱Oral Complications of Cancer Chemotherapy讀者反饋




書目名稱Oral Complications of Cancer Chemotherapy讀者反饋學科排名

成績上升

Intercept

978-1-4613-3914-4Martinus Nijhoff Publishers, The Hague 1983

intertwine

Developments in Oncologyhttp://image.papertrans.cn/o/image/703525.jpg

FLAGR

https://doi.org/10.1007/978-1-4613-3912-0cancer treatment; histopathology; pain; pathology; pharmacology; prevention; transplantation

滲入

Samuel Dreizen D.D.S., M.D.,Lee R. Brown Ph.D.im Gefolge des ?Reformgeistes‘der sp?ten sechziger und frühen siebziger Jahre entstanden. In der jüngsten Zeit hat die ?ffentliche Diskussion materieller Beteiligungsbestrebungen dadurch besondere Impulse erhalten, da? die Aufstockung des Verm?gensbildungsgesetzes auf 936 DM an eine Beteiligung der

fixed-joint

Douglas E. Peterson D.M.D., Ph.D.im Gefolge des ?Reformgeistes‘der sp?ten sechziger und frühen siebziger Jahre entstanden. In der jüngsten Zeit hat die ?ffentliche Diskussion materieller Beteiligungsbestrebungen dadurch besondere Impulse erhalten, da? die Aufstockung des Verm?gensbildungsgesetzes auf 936 DM an eine Beteiligung der

微枝末節(jié)

Pharmacology of Chemotherapeutic Agents,or research, the increased search for substances with anticancer activity, and the development of new methods for drug screening such as new transplantable animal tumors to screen for active drugs [4].

品牌

Principles of Infection Management and Prevention,thogens requires a basic understanding of the epidemiology of these infections as well as a systematic approach to diagnosis and treatment. In addition, there is a constant evolution in the type and site of infection involved so that all members of the health care delivery team must be cognizant of

confide

Book 1983upled with an appreciation for advances in other areas of supportive care, such as antiemetic therapy and pain control, will allow all those involved in cancer treatment to be more successful. Peter H. Wiernik, M.D. Emil Frei, M.D.